Kangmei Pharma | 600518 - Trade Creditors

Stock Price
1.61
Daily Change
-0.01 -0.62%
Monthly
-8.00%
Yearly
-18.69%
Q2 Forecast
1.59

Kangmei Pharma reported CNY2.61B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
Avita Medical AUD 8.96M 1.69M Dec/2025
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Dianthus Therapeutics USD 5.27M 4.45M Mar/2026
Genomma Lab Internacional MXN 1.76B 1.99B Mar/2026
Hypermarcas BRL 583.2M 29.42M Dec/2025
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
IQVIA Holdings USD 3.64B 112M Mar/2026
Jiangsu Hengrui CNY 2.33B 64.06M Mar/2026
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Moderna USD 161M 156M Mar/2026
Organon & Co USD 983M 31M Mar/2026
Revvity USD 169.68M 15.78M Mar/2026
Sh Fosun Pharma CNY 4.62B 237.97M Mar/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Viatris USD 1.2B 93.9M Mar/2026
Wuxi Apptec CNY 2.85B 401.85M Mar/2026
Xeris Pharmaceuticals USD 11.47M 8.39M Mar/2026
Zz Pientze Pharmaceu CNY 457.05M 59.09M Mar/2026